Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

MDGL Madrigal Pharmaceuticals Inc

206,92

-1,12 (-0,54%)

Nach Börsenschluss

Zuletzt aktualisiert: 00:57:58

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Madrigal Pharmaceuticals Charts.

Madrigal Pharmaceuticals (NASDAQ:MDGL)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Madrigal Pharmaceuticals Charts.

News Madrigal Pharmaceuticals Inc

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
Dienstag 7 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Madrigal Statement on the Passing of Dr. Stephen Harrison
Mittwoch 24 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024
Dienstag 23 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Dienstag 16 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Mittwoch 3 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
Dienstag 19 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Madrigal Pharmaceuticals Inc News-Artikel

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Euro vs Sterling

Gold vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen